JACC:卵圆孔封堵术可以缓解偏头痛?

2017-12-06 MedSci MedSci原创

偏头痛是一种较普遍且棘手的疾病,既往研究显示卵圆孔未闭(PFO)与偏头痛存在关联性,但其在偏头痛中的具体机制尚未阐明。本研究的目的旨在评估经皮PFO封堵术在有或无先兆的偏头痛中的疗效性。PREMIUM临床研究是随机双盲试验,将偏头痛患者随机分成药物治疗加假手术组和药物联合经皮卵圆孔封堵术治疗组,并随访观察1年患者的临床特征。主要终点事件是偏头痛和相关不良反应发生率至少减少50%,次要终点事件是患者

偏头痛是一种较普遍且棘手的疾病,既往研究显示卵圆孔未闭(PFO)与偏头痛存在关联性,但其在偏头痛中的具体机制尚未阐明。

本研究的目的旨在评估经皮PFO封堵术在有或无先兆的偏头痛中的疗效性。

PREMIUM临床研究是随机双盲试验,将偏头痛患者随机分成药物治疗加假手术组和药物联合经皮卵圆孔封堵术治疗组,并随访观察1年患者的临床特征。主要终点事件是偏头痛和相关不良反应发生率至少减少50%,次要终点事件是患者偏头痛天数的减少。最终,本研究共纳入230名偏头痛患者,主要终点事件发生率在两组患者见无明显差异,相比于对照组,药物联合经皮卵圆孔封堵术治疗组患者的偏头痛天数明显更少(-3.4 vs. -2.0天/年,p=0.025),偏头痛的完全缓解率也更高(8.5% vs 1%,p=0.01)。

PREMIUM临床研究结果显示,经皮卵圆孔封堵术治疗组患者没有达到主要终点事件。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2060985, encodeId=5d542060985f0, content=<a href='/topic/show?id=e70046e74d3' target=_blank style='color:#2F92EE;'>#封堵术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46774, encryptionId=e70046e74d3, topicName=封堵术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Sat May 19 02:37:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853865, encodeId=da40185386583, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Aug 25 07:37:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325625, encodeId=3089132562574, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Fri Dec 08 07:37:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267293, encodeId=1af626e2936e, content=有一个新发现, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/30yrQPYKndeHChDiaiaxia9cGlrfibfht87aw13tZ9Uibdql4ibxeovoZJDoBWhQpwsuO2tL8MHicYAbI5Gsa5ic97eBGA/132, createdBy=0ddc2188194, createdName=董海鹏, createdTime=Wed Dec 06 16:55:34 CST 2017, time=2017-12-06, status=1, ipAttribution=)]
    2018-05-19 ycmayy
  2. [GetPortalCommentsPageByObjectIdResponse(id=2060985, encodeId=5d542060985f0, content=<a href='/topic/show?id=e70046e74d3' target=_blank style='color:#2F92EE;'>#封堵术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46774, encryptionId=e70046e74d3, topicName=封堵术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Sat May 19 02:37:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853865, encodeId=da40185386583, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Aug 25 07:37:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325625, encodeId=3089132562574, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Fri Dec 08 07:37:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267293, encodeId=1af626e2936e, content=有一个新发现, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/30yrQPYKndeHChDiaiaxia9cGlrfibfht87aw13tZ9Uibdql4ibxeovoZJDoBWhQpwsuO2tL8MHicYAbI5Gsa5ic97eBGA/132, createdBy=0ddc2188194, createdName=董海鹏, createdTime=Wed Dec 06 16:55:34 CST 2017, time=2017-12-06, status=1, ipAttribution=)]
    2018-08-25 hbwxf
  3. [GetPortalCommentsPageByObjectIdResponse(id=2060985, encodeId=5d542060985f0, content=<a href='/topic/show?id=e70046e74d3' target=_blank style='color:#2F92EE;'>#封堵术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46774, encryptionId=e70046e74d3, topicName=封堵术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Sat May 19 02:37:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853865, encodeId=da40185386583, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Aug 25 07:37:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325625, encodeId=3089132562574, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Fri Dec 08 07:37:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267293, encodeId=1af626e2936e, content=有一个新发现, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/30yrQPYKndeHChDiaiaxia9cGlrfibfht87aw13tZ9Uibdql4ibxeovoZJDoBWhQpwsuO2tL8MHicYAbI5Gsa5ic97eBGA/132, createdBy=0ddc2188194, createdName=董海鹏, createdTime=Wed Dec 06 16:55:34 CST 2017, time=2017-12-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2060985, encodeId=5d542060985f0, content=<a href='/topic/show?id=e70046e74d3' target=_blank style='color:#2F92EE;'>#封堵术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46774, encryptionId=e70046e74d3, topicName=封堵术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Sat May 19 02:37:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853865, encodeId=da40185386583, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Aug 25 07:37:00 CST 2018, time=2018-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325625, encodeId=3089132562574, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Fri Dec 08 07:37:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267293, encodeId=1af626e2936e, content=有一个新发现, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/30yrQPYKndeHChDiaiaxia9cGlrfibfht87aw13tZ9Uibdql4ibxeovoZJDoBWhQpwsuO2tL8MHicYAbI5Gsa5ic97eBGA/132, createdBy=0ddc2188194, createdName=董海鹏, createdTime=Wed Dec 06 16:55:34 CST 2017, time=2017-12-06, status=1, ipAttribution=)]
    2017-12-06 董海鹏

    有一个新发现

    0

相关资讯

JACC:氙气联合降体温治疗能明显减少心脏停搏患者心肌损伤

近期有研究表明,吸入氙气并降低体温可以减少院外心脏停搏昏迷患者(OHCA)的大脑白质损伤,本研究的目的旨在评估氙气的吸入对OHCA患者心肌缺血的影响。本研究纳入了110名OHCA患者,并将其随机分成吸入氙气并降低体温治疗组(n=55人,氙气组)和仅仅降低体温治疗组(n=55人,对照组)。并对所有患者在入院时、心脏停搏后24h、48h和72h进行肌钙蛋白T水平的检测,最终两组患者各有54名接受了肌钙

JACC:诊断时间与扩张型心肌病患儿的预后相关

研究表明扩张型心肌病(DCM)患儿生存率的提高很大一部分是由于接受了心脏移植。本研究的目的旨在评估没有接受心脏移植的DCM患儿的生存率和探究影响死亡率的临床特征。本研究纳入了<18岁的几种DCM类型患者,并根据诊断时间分为早期组(1990-1999)和晚期组(2000-2009),最终共纳入了1953名DCM患儿,其中早期组有1199例,晚期组有754例。两组患者的DCM大多数均为自发性(64%

JACC:腹型肥胖能明显增加心衰患者死亡率!

目前,尚缺乏探究腹型肥胖与心衰伴保留型射血分数(HFpEF)患者预后的相关研究。本研究的目的旨在探究腹型肥胖与HFpEF患者全因死亡率的关系。本研究的数据来自TOPCAT临床试验,主要终点事件为全因死亡率,腹型肥胖的定义标准为男性腰围≥102cm,女性腰围≥88cm。最终功能纳入了3310名HFpEF患者,其中腹型肥胖的为2413名,非腹型肥胖的为897名。平均随访时间为3.4 ± 1.7年,随访

JACC:主动脉瓣置换术在单纯性主动脉反流患者中的预后研究

目前,尚缺乏主动脉瓣置换术(TAVR)在单纯性主动脉反流(AR)病人中的安全性和有效性资料。本研究的目的旨在比较评估早期和新一代TAVR装置在单纯性AR患者中的预后结局。本研究共纳入了331名接受过TAVR的平均STS评分为6.7 ± 6.7的患者,其中分别有119 名患者(36.0%) 和212 名患者 (64.0%)接受了早期和新一代TAVR装置。STS评分在接受新一代TAVR装置患者中更低(

口腔问题增加心血管、脑卒中、癌症风险

口腔清新整洁,不仅是礼仪问题,更是健康问题,牵涉心脑肾,还有癌症预防问题。

CIRC RES:平滑肌细胞在血管发育和修复中的作用研究

血管平滑肌细胞收缩在血管损伤修复和心血管疾病发展过程中起到重要作用,然而,目前尚缺乏特异的转基因动物模型在体内证实。本研究证实CD146在血管平滑肌细胞发育过程中有瞬时表达现象,通过CRISPR-Cas9基因编辑技术和体外平滑肌分化实验证实CD146在调控血管平滑肌细胞增殖和分化平衡中起到重要作用,并利用三重转基因小鼠模型追溯NG2+CD146+未成熟平滑肌细胞的起源,结果发现动脉的平滑肌细胞起源